Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment for heroin, methamphetamine and cocaine addiction.
Summary
Bill S01817 seeks to amend the mental hygiene law in New York by requiring the office of addiction services and supports to promote and facilitate clinical research into the use of ibogaine as a treatment for addiction to heroin, methamphetamine, and cocaine. This initiative aims to explore alternative treatment options for substance use disorders, particularly for individuals struggling with these specific addictions. The bill emphasizes the need for scientific investigation into ibogaine's efficacy and safety in clinical settings, potentially leading to new therapeutic avenues for addiction treatment.
Impact
If enacted, this bill would modify existing state laws by mandating the office of addiction services and supports to actively engage in research related to ibogaine. This could lead to the establishment of new protocols and guidelines for addiction treatment in New York, potentially influencing how addiction services are delivered and funded. The bill may also align New York with emerging trends in addiction treatment that explore the use of psychedelic substances, which could have broader implications for mental health and addiction policy in the state.
Sentiment
The sentiment surrounding Bill S01817 appears to be positive, as indicated by the unanimous support in the Senate Alcoholism and Substance Use Disorders Committee vote, where all five members voted in favor. This suggests a growing recognition of the need for innovative approaches to addiction treatment and a willingness to explore unconventional methods. However, the lack of extensive public discussion or opposition in the provided context may indicate that the bill has not yet faced significant scrutiny or debate.
Contention
While the bill currently enjoys support within the committee, potential points of contention could arise as it progresses. Critics may raise concerns about the safety and efficacy of ibogaine, as well as the ethical implications of using psychedelic substances in treatment. Additionally, there may be differing opinions on resource allocation for research into ibogaine versus other established treatment modalities. Stakeholders in the addiction treatment community may have varying perspectives on the appropriateness of this approach, which could lead to future debates.
Same As
Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment for heroin, methamphetamine and cocaine addiction.
Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment for heroin, methamphetamine and cocaine addiction.
Requires the office of addiction services and supports to collect certain demographic data for incarcerated individuals in medication assisted treatment programs.
Requires the office of addiction services and supports to collect certain demographic data for incarcerated individuals in medication assisted treatment programs.
Requires rates paid for rehabilitation and opioid treatment be pursuant to certain fee schedules published by the office of addiction services and supports.
Requires the office of addiction services and supports and the office of mental health to publish information for calculation of rates paid for certain treatment pursuant to the medical assistance program in a form an manner prescribed by the commissioner of the office of addiction services and supports or the commissioner of mental health, as applicable.
Establishes an intensive addiction recovery and mental health integrated services pilot program to support two three-year demonstration programs that provide intensive addiction and mental health integrated services to individuals with significant addiction and mental health issues who have had multiple and frequent treatment episodes.
Expands the purposes of the drug treatment and public education fund to include prevention and recovery programs; requires reporting to be made available on the office of addiction services and supports' website.
Requires rates paid for rehabilitation and opioid treatment be pursuant to certain fee schedules published by the office of addiction services and supports.
Requires the office of addiction services and supports and the office of mental health to publish information for calculation of rates paid for certain treatment pursuant to the medical assistance program in a form an manner prescribed by the commissioner of the office of addiction services and supports or the commissioner of mental health, as applicable.
Establishes a research grant program to fund clinical trials of ibogaine for the treatment of veterans for post-traumatic stress disorder; creates a fund to provide monies for the research grant program.